About us   Become an industry partner

Become an industry partner

The success of the CLL IC Taskforce will rely on collaboration across the CLL community, including the support of committed partners. By focusing on quality of life and best practice clinical care, we are working to close key gaps in care and reduce the impact of immune challenges experienced for people living with CLL.

The CLL IC Taskforce is currently supported with funding from AstraZeneca, Takeda, Johnson & Johnson and Lilly. We welcome additional industry partners to participate in the CLL IC Taskforce.

Benefits of becoming an industry partner can include:

• Being a full member of the Steering Committee (major funder) and each working group to jointly shape the direction of the project with other stakeholder members.
• Contribute to the development of deliverables alongside other stakeholder members.
• Having your company logo on final deliverables alongside the logos of other CLL IC Taskforce members.

By supporting this initiative, you will help deliver real-world solutions to improve patient outcomes. Contact Jan Rynne at jan@clladvocates.net to explore funding opportunities.